European CommissionCompetition policy

The European Commission’s probe into suspected anti-trust activity in the pharmaceutical sector is rumbling on, with further dawn raids earlier this week.

The EC has published a non-confidential version of the ruling that Intel broke antitrust rules by excluding competitors from the market for x86 computer chips.

Anti-trust legislation, particularly involving raids at dawn, is no way to improve productivity in the pharmaceutical industry, says Nuala Moran.

Microsoft has agreed to allow access to its technology following the court ruling last month, a move the European Commission says will lead to more innovation in the software market.